Aptose Biosciences Inc. APTO NASDAQ

Aptose Biosciences Inc. (APTO) reported total assets of $10.01M and total liabilities of $37.18M for quarter ending 2025-12-31, resulting in total equity of $-27.17M.

The company held $935K in cash and short-term investments. Total debt stood at $193K, with net debt of $-742K. The Debt-to-Equity (D/E) ratio was -0.01 (conservative).

Current ratio is 0.69, which may signal tight short-term liquidity. Interest coverage is 4.4x (adequate).

Criteria supported by this page:

• HEALTH (0/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
• MOAT (28/100) — Total assets $10.01M and equity $-27.17M support the company's competitive scale

Overall SharesGrow Score: 43/100 with 2/7 criteria passed.